SOURCE: American Society for Radiation Oncology

American Society for Radiation Oncology

February 15, 2016 18:55 ET

Leading Oncology Research to be Highlighted in News Briefings at the 2016 Multidisciplinary Head and Neck Cancer Symposium

News Briefings Also Available Live via Webcast

SCOTTSDALE, AZ--(Marketwired - February 15, 2016) - The 2016 Multidisciplinary Head and Neck Cancer Symposium, sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO) and the American Head & Neck Society (AHNS), will explore the heterogeneous group of tumors in head and neck cancers and the various complexities and factors in providing treatment. The multidisciplinary approach includes surgery, radiation therapy and chemotherapy in addition to novel molecular biologic therapies that show promise in improving patient outcomes.

The two-and-a-half day meeting will feature the largest number of abstracts in its history, selected from a record-breaking number of submissions. Interactive educational sessions will focus on novel multidisciplinary therapies, directed therapy, treatment guidelines, prevention, surveillance and supportive care. A total of 262 abstracts, including 13 oral abstract presentations and 249 posters, will highlight the most current, cutting-edge science of relevance to the head and neck cancer community.

Keynote speakers include:

  • Tanguy Seiwert, MD, University of Chicago, "Immunotherapy for Head and Neck Cancer"
  • Robert I. Haddad, MD, Brigham and Women's Hospital, "Personalized Treatment for Head and Neck Cancer -- The Time is Now"
  • Quynh-Thu Le, MD, FASTRO, Stanford School of Medicine, "Precision Therapy in Head and Neck Cancer -- From Technology to Biomarker-based Risk Stratification"
  • Neil Hayes, MD, MPH, UNC School of Medicine, "Genome Atlas and Sequencing Data: How We Use This Going Forward"

When: Thursday, February 18 - Saturday, February 20, 2016

Where:  JW Marriott Camelback Inn Resort and Spa, Scottsdale, Arizona

News Briefings:  

  • Prognostic Factors in Head and Neck Cancer, Thursday, February 18, 7:00 a.m. - 7:45 a.m. MT (9:00 a.m. ET)
  • Optimizing Head and Neck Cancer Treatment with Limited Resources, Friday, February 19, 7:00 a.m. - 7:45 a.m. MT (9:00 a.m. ET)

News briefings will be available via live webcast for registered press. Visit www.astro.org/HNpress for links, as well as audio recordings and presentation slides posted following each briefing.

Press Registration: Credentialed journalists from accredited news organizations are invited to attend and report on the 2016 Multidisciplinary Head and Neck Cancer Symposium. The Press Policies and Registration Form are available at the ASTRO website.

Press Office:  Town Hall Room, JW Marriott Camelback Inn Resort and Spa, Scottsdale, AZ; Open Thursday, Feb. 18 and Friday, Feb. 19 from 8:00 a.m. to 4:00 p.m. MT

More information is available at the 2016 Multidisciplinary Head and Neck Cancer Symposium website, www.headandnecksymposium.org.

ABOUT ASTRO

ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology • Biology • Physics (www.redjournal.org), Practical Radiation Oncology (www.practicalradonc.org) and Advances in Radiation Oncology (www.advancesradonc.org); developed and maintains an extensive patient website, RT Answers (http://www.rtanswers.org); and created the Radiation Oncology Institute (www.roinstitute.org), a nonprofit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit www.astro.org.

ABOUT ASCO

Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With nearly 40,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.cancer.net.

ABOUT AHNS

The American Head & Neck Society (AHNS) is the single largest organization in North America for the advancement of research and education in head and neck oncology. The mission of the American Head and Neck Society is: to promote and advance the knowledge of prevention, diagnosis, treatment, and rehabilitation of neoplasms and other diseases of the head and neck; to promote and advance research in diseases of the head and neck, and; to promote and advance the highest professional and ethical standards. For more information, visit www.ahns.info.

Contact Information